Publications by authors named "Shi-wei He"

Article Synopsis
  • Researchers studied a specific enzyme called USP44 to understand its role in a type of cancer called neuroblastoma, especially in patients with advanced disease.
  • They found that low levels of USP44 were linked to worse outcomes, but when USP44 was increased, cancer cells became more sensitive to a treatment called cisplatin.
  • The study showed that USP44 works with another protein, STUB1, to break down a different protein, LRPPRC, which helps cancer cells die faster when treated with cisplatin, making it a possible target for future treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists found a long non-coding RNA (lncRNA) called SIMALR that is highly active in a type of throat cancer called nasopharyngeal carcinoma (NPC).
  • SIMALR is important because it helps cancer cells grow and spread, and its high levels can predict worse outcomes for patients.
  • SIMALR works by helping a protein called eEF1A2 to make other proteins faster, which pushes cancer cells to be more aggressive.
View Article and Find Full Text PDF
Article Synopsis
  • Docetaxel combined with cisplatin and 5-fluorouracil (TPF) is the main treatment for advanced nasopharyngeal carcinoma (NPC), but some patients do not respond well, with the reasons for this remaining unclear.* -
  • DCAF7 has been identified as a gene that contributes to chemoresistance in NPC by enhancing cisplatin resistance and promoting cell metastasis, functioning as a scaffold protein that stabilizes G3BP1 and helps form stress granules.* -
  • High levels of DCAF7 in NPC patients are associated with a greater risk of metastasis and poorer prognosis, indicating that targeting the DCAF7-USP10-G3BP1 pathway could
View Article and Find Full Text PDF

The key to enhancing water electrolysis efficiency lies in selecting highly efficient catalysts. Currently, high-entropy alloys (HEAs) are utilized in electrocatalysis applications owing to their diverse elemental composition, disordered elemental distribution, and the high solubility of each element, endowing them with excellent catalytic performance. The experiments were conducted using isoatomic FeNiCrMo HEA as a precursor, with a high-activity three-dimensional nanoporous structure rapidly synthesized via electrochemical one-step dealloying in a choline chloride-thiourea (ChCl-TU) deep eutectic solvent (DES).

View Article and Find Full Text PDF

Gemcitabine (GEM) based induction chemotherapy is a standard treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, approximately 15 % of patients are still resistant to GEM-containing chemotherapy, which leads to treatment failure. Nevertheless, the underlying mechanisms of GEM resistance remain poorly understood.

View Article and Find Full Text PDF

Chemoresistance is a main reason for treatment failure in patients with nasopharyngeal carcinoma, but the exact regulatory mechanism underlying chemoresistance in nasopharyngeal carcinoma remains to be elucidated. Here, we identify PJA1 as a key E3 ubiquitin ligase involved in nasopharyngeal carcinoma chemoresistance that is highly expressed in nasopharyngeal carcinoma patients with nonresponse to docetaxel-cisplatin-5-fluorouracil induction chemotherapy. We find that PJA1 facilitates docetaxel resistance by inhibiting GSDME-mediated pyroptosis in nasopharyngeal carcinoma cells.

View Article and Find Full Text PDF

Despite that the docectaxel-cisplatin-5-fluorouracil (TPF) induction chemotherapy has greatly improved patients' survival and became the first-line treatment for advanced nasopharyngeal carcinoma (NPC), not all patients could benefit from this therapy. The mechanism underlying the TPF chemoresistance remains unclear. Here, by analyzing gene-expression microarray data and survival of patients who received TPF chemotherapy, we identify transcription factor ATMIN as a chemoresistance gene in response to TPF chemotherapy in NPC.

View Article and Find Full Text PDF

Background: Metastasis has emerged as the major reason of treatment failure and mortality in patients with nasopharyngeal carcinoma (NPC). Growing evidence links abnormal DNA methylation to the initiation and progression of NPC. However, the precise regulatory mechanism behind these processes remains poorly understood.

View Article and Find Full Text PDF

Emerging evidence indicates that DNA methylation plays an important role in the initiation and progression of nasopharyngeal carcinoma (NPC). DNAJA4 is hypermethylated in NPC, while its role in regulating NPC progression remains unclear. Here, we revealed that the promoter of DNAJA4 was hypermethylated and its expression was downregulated in NPC tissues and cells.

View Article and Find Full Text PDF

Gemcitabine plus cisplatin (GP) chemotherapy is the standard of care for nasopharyngeal carcinoma (NPC). However, the mechanisms underpinning its clinical activity are unclear. Here, using single-cell RNA sequencing and T cell and B cell receptor sequencing of matched, treatment-naive and post-GP chemotherapy NPC samples (n = 15 pairs), we show that GP chemotherapy activated an innate-like B cell (ILB)-dominant antitumor immune response.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers found that a special type of RNA called LINC00839 is linked to increased cancer growth and bad outcomes for people with nasopharyngeal carcinoma (NPC).
  • This RNA boosts the activity of a protein important for cancer, which leads to more NPC growth and spreads.
  • The study shows how LINC00839 works together with other proteins to help the cancer grow and suggests that targeting it could be important for treatment.
View Article and Find Full Text PDF

Although radiotherapy can promote antitumour immunity, the mechanisms underlying this phenomenon remain unclear. Here, we demonstrate that the expression of the E3 ubiquitin ligase, tumour cell-intrinsic tripartite motif-containing 21 (TRIM21) in tumours, is inversely associated with the response to radiation and CD8 T cell-mediated antitumour immunity in nasopharyngeal carcinoma (NPC). Knockout of TRIM21 modulates the cGAS/STING cytosolic DNA sensing pathway, potentiates the antigen-presenting capacity of NPC cells, and activates cytotoxic T cell-mediated antitumour immunity in response to radiation.

View Article and Find Full Text PDF

An increasing number of studies have found that long non-coding RNA (lncRNA) play important roles in driving the progression of nasopharyngeal carcinoma (NPC). Our microarray screening revealed that expression of the lncRNA long intergenic non-protein coding RNA 173 (LINC00173) was upregulated in NPC. However, its role and mechanism in NPC have not yet been elucidated.

View Article and Find Full Text PDF

Sialoblastoma (SBL) is an infrequent embryonal malignant tumor originating from the salivary gland, resembling primitive salivary gland anlage, whereas hepatoblastoma (HB) is the most common pediatric liver malignancy. The simultaneous occurrence of both tumors is extremely rare. Here we reported a case of a 6-month-old infant diagnosed with synchronous SBL and HB.

View Article and Find Full Text PDF
Article Synopsis
  • Nasopharyngeal carcinoma (NPC) has the highest metastasis rate among head and neck cancers, and distant metastasis leads to therapy failure and high mortality, indicating the need for new biomarkers for treatment.
  • This study found that WIPI-1, a protein whose expression is significantly lower in NPC cells and tissues, is associated with poor patient prognosis and plays a critical role in regulating NPC cell behavior, including migration and proliferation.
  • WIPI-1 has been identified as a tumor suppressor that inhibits tumor growth and metastasis by enhancing autophagy and interacting with TRIM21, suggesting that targeting WIPI-1 could offer a promising new treatment approach for NPC.
View Article and Find Full Text PDF

In a recently published phase III clinical trial, gemcitabine (GEM) plus cisplatin (DDP) induction chemotherapy significantly improved recurrence-free survival and overall survival and became the standard of care among patients with locoregionally advanced NPC. However, the molecular mechanisms of GEM synergized with DPP in NPC cells remain elucidated. These findings prompt us to explore the effect of the combination between GEM and DDP in NPC cell lines through proliferative phenotype, immunofluorescence, flow cytometry, and western blotting assays.

View Article and Find Full Text PDF

Non-keratinizing nasopharyngeal carcinoma, the major subtype of nasopharyngeal carcinoma, is characterized by low differentiation and a close relation to Epstein-Barr virus infection, which indicates a link between Epstein-Barr virus oncogenesis and loss of differentiation, and raises our interest in investigating the involvement of Epstein-Barr virus in nasopharyngeal carcinoma dedifferentiation. Our previous study showed abundant expression of an Epstein-Barr virus-encoded microRNA, BART10-3p, in nasopharyngeal carcinoma tissues, but the association between BART10-3p and nasopharyngeal carcinoma differentiation remains unknown. Here, we examined the expression and prognostic value of BART10-3p, and undertook bioinformatics analysis and functional assays to investigate the influence of BART10-3p on nasopharyngeal carcinoma differentiation and proliferation and the underpinning mechanism.

View Article and Find Full Text PDF

Purpose: Serum cystatin C has been considered as a significant prognostic factor for various malignancies. This study aimed to evaluate the relationship between serum cystatin C level before antitumor treatment and the prognosis of nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT).

Patients And Methods: A cohort of 2077 NPC patients were enrolled between April 2009 and September 2012.

View Article and Find Full Text PDF

Purpose: The prognostic value of serum calcium levels in nasopharyngeal carcinoma (NPC) remains unknown. This study aimed to evaluate the prognostic value of serum calcium levels in patients with NPC.

Patients And Methods: A total of 2094 patients diagnosed with NPC between April 2009 and September 2012 were enrolled in this retrospective analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying how a gene called ZNF582 affects the spread of a type of cancer called nasopharyngeal carcinoma (NPC).
  • They found that ZNF582 is not working properly in NPC tissues, which leads to more cancer growth and spread.
  • By understanding how ZNF582 works, they believe it could help in creating new treatments for NPC by focusing on related genes.
View Article and Find Full Text PDF

Background: Tumor-infiltrating lymphocytes have been reported as prognostic markers in tumors. We aimed to assess the prognostic value of total T cell (CD3) density, cytotoxic T cell (CD8) density and memory T cell (CD45RO) density in patients with nasopharyngeal carcinoma (NPC).

Methods: The expression of CD3, CD8 and CD45RO was detected by immunohistochemistry in the training (n=221) and validation cohorts (n=115).

View Article and Find Full Text PDF

Increasing evidence indicates that long non-coding RNAs (lncRNAs) play vital roles in the tumorigenesis and progression of cancers. However, the functions and regulatory mechanisms of lncRNAs in nasopharyngeal carcinoma (NPC) are still largely unknown. Our previous lncRNA expression profiles identified that LINC01503 was overexpressed in NPC.

View Article and Find Full Text PDF

Background: This study will evaluate the effectiveness and safety of respiratory muscle training (RMT) for patients with obstructive sleep apnea (OSA).

Methods: Randomized controlled trials will be retrieved through electronic database searches from MEDLINE, EMBASE, Cochrane Library, CINAHL, Scopus, CBM, and CNKI from the beginning to the present. All electronic databases will be searched without any language limitation.

View Article and Find Full Text PDF